Masimo Corp (MASI)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

52 DISCOVERY IRVINE, CA 92618

Masimo Corporation engages in the development, licensing, and marketing of advanced signal processing technologies and products for the noninvasive monitoring of vital signs. The company licenses its Masimo Signal Extraction Technology pulse oximetry, Masimo SET, to approximately 35 international patient monitoring systems providers.

Data based on most recent fiscal year report
Market Cap4.429 Billion Shares Outstanding51.67 Million Avg Volume925.903 Thousand
1-Yr BETA vs S&P TR1.215 Current Ratio3.72 Quick Ratio3.09
View SEC Filings from MASI instead.
Q3 2019 All Institutions Hedge Funds 1
To trade MASI now:
Filers who had this stock in their top 10: 4 2 (0.21%)
13F Filers holding this stock: 376 43 (4.49%)
Aggregate 13F shares on 09/30/2019: 43.717 Million 2.246 Million
Aggregate 13F shares on 06/30/2019: 44.337 Million 3.178 Million
Percent change: -1.40% -29.33%
Funds creating new positions: 47 6
Funds Adding to an existing position: 110 7
Funds closing out their position: 40 6
Funds reducing their position: 164 26
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MASI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

44 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

44 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FITCH SANFORD

  • Director
44,245 2019-12-06 5

SAMPATH ANAND EVP, OPS & CLINICAL RESEARCH

  • Officer
12,518 2019-11-20 5

LEE YONGSAM EVP & CIO

  • Officer
73,000 2019-11-19 10

MUHSIN BILAL CHIEF OPERATING OFFICER

  • Officer
0 2019-11-18 5

LASERSOHN JACK W

  • Director
5,060 2019-10-01 0

YOUNG MICAH W EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2019-09-16 2

SHIMER JULIE ANN

  • Director
7,756 2019-08-16 2

CAHILL EDWARD L

  • Director
3,982 2019-08-13 0

KIANI JOE E CEO AND CHAIRMAN OF THE BOARD

  • Officer
  • Director
3,900,109 2019-07-31 6

BARKER STEVEN

  • Director
66,245 2019-07-26 8

REYNOLDS CRAIG B

0 2019-07-24 1

HARKIN THOMAS

  • Director
6,381 2019-05-30 1

MIKKELSON ADAM

  • Director
2,996 2019-05-30 1

COHEN H MICHAEL

  • Director
0 2019-05-30 1

VAN RAMSHORST DAVID J CHIEF ACCOUNTING OFFICER

  • Officer
1,000 2019-05-16 3

COLEMAN JON PRES-WW SALES,PRO SVC,MED AFFS

  • Officer
11,201 2019-04-01 7

MCCLENAHAN THOMAS SAMUEL EVP & GENERAL COUNSEL

  • Officer
0 2019-03-15 2

LEVY TAO EVP, BUS DEV

  • Officer
0 2019-03-15 1

GOODMAN DAVID

  • Director
0 2018-05-01 0

FISHEL RICK PRES, WW OEM BUSINESS...

  • Officer
20,022 2017-07-14 0

DE RAAD MARK EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2017-06-05 0

LECLERCQ THIERRY EVP, BUS DEV

  • Officer
0 2017-05-08 0

JANSEN PAUL EVP, BUS DEV

  • Officer
6,389 2017-03-08 0

ALLAN ANTHONY SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2014-06-20 0

COLEMAN ROBERT

  • Director
0 2014-02-18 0

PAUL STEPHEN E. EVP, ACUTE CARE SALES

  • Officer
6,000 2011-05-02 0

O'REILLY MICHAEL CHIEF MEDICAL OFFICER

  • Officer
0 2011-02-22 0

AL-ALI AMMAR

  • CHIEF ENGINEER
No longer subject to file 2010-02-11 0

CAMPBELL BRIAN

  • VP, OPERATIONS
0 2009-10-05 0

MORAN STEPHEN M EVP, GENERAL COUNSEL

  • Officer
0 2008-07-14 0

BERTHON OLIVIER PRESIDENT, MASIMO EUROPE

  • Officer
74,250 2008-05-14 0

MANIWA TETSURO PRESIDENT, MASIMO JAPAN

  • Officer
0 2008-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FITCH SANFORD - Director

2019-12-06 M 7,000 $41.80 d 0 44,245.00 direct

FITCH SANFORD - Director

2019-12-06 S 7,000 $156.27 d 44,245 44,245.00 direct yes

FITCH SANFORD - Director

2019-12-06 M 7,000 $41.80 a 51,245 44,245.00 direct

LEE YONGSAM - Officer EVP & CIO

2019-11-20 M 10,675 $28.03 d 10,000 73,000.00 direct

LEE YONGSAM - Officer EVP & CIO

2019-11-20 M 10,675 $28.03 a 83,675 73,000.00 direct

SAMPATH ANAND - Officer EVP, OPS & CLINICAL RESEARCH

2019-11-20 M 15,000 $31.01 d 15,000 12,518.00 direct

SAMPATH ANAND - Officer EVP, OPS & CLINICAL RESEARCH

2019-11-20 S 15,000 $155.00 d 12,518 12,518.00 direct yes

LEE YONGSAM - Officer EVP & CIO

2019-11-20 S 10,675 $155.03 d 73,000 73,000.00 direct yes

SAMPATH ANAND - Officer EVP, OPS & CLINICAL RESEARCH

2019-11-20 M 15,000 $31.01 a 27,518 12,518.00 direct

LEE YONGSAM - Officer EVP & CIO

2019-11-19 M 1,825 $28.03 d 20,675 73,000.00 direct

LEE YONGSAM - Officer EVP & CIO

2019-11-19 S 1,825 $153.16 d 73,000 73,000.00 direct yes

LEE YONGSAM - Officer EVP & CIO

2019-11-19 M 1,825 $28.03 a 74,825 73,000.00 direct

MUHSIN BILAL - Officer CHIEF OPERATING OFFICER

2019-11-18 M 3,000 $21.69 d 2,000 0.00 direct

MUHSIN BILAL - Officer CHIEF OPERATING OFFICER

2019-11-18 S 3,000 $150.00 d 0 0.00 direct yes

MUHSIN BILAL - Officer CHIEF OPERATING OFFICER

2019-11-18 M 3,000 $21.69 a 3,000 0.00 direct

FITCH SANFORD - Director

2019-11-04 M 6,500 $41.80 a 50,745 44,245.00 direct

FITCH SANFORD - Director

2019-11-04 M 6,500 $41.80 d 7,000 44,245.00 direct

FITCH SANFORD - Director

2019-11-04 S 6,500 $147.08 d 44,245 44,245.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments